EBS - Emergent BioSolutions' (EBS) CEO Dan Abdun-Nabi on Q4 2018 Results - Earnings Call Transcript
Emergent BioSolutions Inc. (EBS)
Q4 2018 Earnings Conference Call
February 21, 2019 5:00 PM ET
Company Participants
Bob Burrows — Vice President-Investor Relations
Dan Abdun-Nabi — Chief Executive Officer
Bob Kramer — President and Chief Operating Officer
Rich Lindahl — Chief Financial Officer
Atul Saran — Executive Vice President, Corporate Development and General Counsel
Doug White — Senior Vice President, Devices Business Unit Head
Abby Jenkins — Senior Vice President, Vaccines & Anti-infectives Business Unit Head
Conference Call Participants
Brandon Folkes — Cantor Fitzgerald
Dana Flanders — Goldman Sachs
Jessica Fye — JPMorgan
Boris Peaker